IL6 and breast carcinoma: Furthermore, Sabutoclax not only causes the release of caspase from mitochondria to cause cancer cell apoptosis, but also blocks the interleukin 6/signal transducers and activators of transcription (IL-6/STAT) pathway to eliminate the breast cancer stem cells.